Product Information
MESTINON 60 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $20.7334 per EA under NDC 00187301030. Its NADAC has been published 176 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the pyridostigmine bromide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Bausch Health US LLCNDC
00187301030
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA009829FDA Approved
Before 1982
TE Code
AB
On Market Since
4/6/1955
Pharmacological Classes
Price Statistics
The NADAC for MESTINON 60 MG TABLET has been published 176 times since Nov 28, 2013, and over the history we have for it it has risen 665.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.7334 per EA |
|---|---|
| All-time high | $20.7852 (Aug 13, 2025) |
| All-time low | $2.7081 (Nov 28, 2013) |
| Median price | $11.6704 |
| Average price | $11.2125 |
| Largest weekly change | +66.1% (Dec 18, 2024) |
| Weeks tracked | 176 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+77.7%
5Y
+77.7%
All
+665.6%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pyridostigmine bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MESTINON 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MESTINON 60 MG TABLET, manufactured by Bausch Health US LLC, is $20.7334 per EA (NDC 00187301030), effective Oct 1, 2025.
How has the price of MESTINON 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for MESTINON 60 MG TABLET has risen 665.6%. It has been tracked across 176 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MESTINON 60 MG TABLET?
Since Nov 28, 2013, the NADAC for MESTINON 60 MG TABLET has ranged from a low of $2.7081 (Nov 28, 2013) to a high of $20.7852 (Aug 13, 2025), with a median of $11.6704 per EA.
Are there cheaper alternatives to MESTINON 60 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PYRIDOSTIGMINE BR 60 MG TABLET, is $0.2487 per EA — about 99% below MESTINON 60 MG TABLET.
Who manufactures MESTINON 60 MG TABLET?
MESTINON 60 MG TABLET (NDC 00187301030) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.